Cargando…
Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells
Gastric cancer is the second leading cause of cancer-related death worldwide, with a poor response to current chemotherapy. Danusertib is a pan-inhibitor of the Aurora kinases and a third-generation Bcr-Abl tyrosine kinase inhibitor with potent anticancer effects, but its antitumor effect and underl...
Autores principales: | Yuan, Chun-Xiu, Zhou, Zhi-Wei, Yang, Yin-Xue, He, Zhi-Xu, Zhang, Xueji, Wang, Dong, Yang, Tianxing, Pan, Si-Yuan, Chen, Xiao-Wu, Zhou, Shu-Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354435/ https://www.ncbi.nlm.nih.gov/pubmed/25767376 http://dx.doi.org/10.2147/DDDT.S74964 |
Ejemplares similares
-
Inhibition of mitotic Aurora kinase A by alisertib induces apoptosis and autophagy of human gastric cancer AGS and NCI-N78 cells
por: Yuan, Chun-Xiu, et al.
Publicado: (2015) -
The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells
por: Li, Jin-Ping, et al.
Publicado: (2015) -
A quantitative proteomic response of hepatocellular carcinoma Hep3B cells to danusertib, a pan-Aurora kinase inhibitor
por: Zhu, Qiaohua, et al.
Publicado: (2018) -
Targeting hepatocarcinogenesis model in C56BL6 mice with pan-aurora kinase inhibitor Danusertib
por: Gavriilidis, Paschalis, et al.
Publicado: (2018) -
Influence of pharmacogenetic variability on the pharmacokinetics and toxicity of the aurora kinase inhibitor danusertib
por: Steeghs, Neeltje, et al.
Publicado: (2010)